News | September 08, 2025
Strides partners with Kenox to expand nasal spray portfolio for US market
Kenox to provide formulation and development expertise in orally inhaled and nasal drug products
Kenox to provide formulation and development expertise in orally inhaled and nasal drug products
Agreement further expands Aptar Pharma’s leading position in nasal delivery solutions and addresses significant unmet needs of delivering drugs locally over extended periods
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
The collaboration will combine Firstsource’s AI-first approach with Guidehealth’s expertise in value-based care innovation
Under an exclusive distribution agreement, Sartorius Stedim Biotech will offer Nanotein’s lead products globally
The agreement complements other PPAs for Sandoz production sites globally
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
This partnership aims to address the growing demand for high-quality diagnostics in metropolitan areas
This collaboration aims to bridge India’s talent and translational gap in this rapidly growing field by equipping professionals with practical expertise in the manufacturing of advanced therapies.
Subscribe To Our Newsletter & Stay Updated
